MedInsight presented its research findings on Dipyridamole eye drops at the recent ISVER conference at Kfar Maccabia. For more details see MedInsight LinkedIn Page
Find us on:
MedInsight recently published a comprehensive review of Dipyridamole in Ocular use in the prestigious Journal of Ocular Pharmacology and Therapeutics. To read the full text, click the link.
Our first clinical trial for Dipyridamole eye drop is on track to begin at Wolfson Medical Center's Department of Ophthalmology. This is the first ever clinical trial for a non-surgical treatment for pterygium, and will also measure the effectiveness in dry eye. For more information about Dipyridamole eye drops click here
MedInsight has added a Linkedin page, so that you can keep abreast of all our activities, news, updates and research! Visit our page by clicking on the following link.
MedInsight has been invited to present at the 2016 ISVER conference. Our presentation, entitled “Topical Dipyridamole for Treatment of Pterygium and Associated Dry Eye Symptoms: Analysis of User-Reported Outcomes” will outline the user outcomes thus far. For information about the conference click here.
Copyright 2009-
MedInsight® Research Institute.
All rights reserved.
MedInsight® Research Institute.
All rights reserved.
About LDNscience®
LDNscience® is a public information project of the MedInsight® Research Institute.
MedInsight® Research Institute is a U.S./U.K. based non-profit organization which serves as a platform for researching and indexing available off-label (repurposed) treatments for cancer and chronic diseases.
Sign up for news alerts
MedInsight's Projects:
Dipyridamole Eye Drops
Cureiosity®